18F-Fluciclovine Uptake by an Incidentally Detected Hepatocellular Carcinoma in a Case of Biochemically Recurrent Prostate Cancer.
Clin Nucl Med
; 43(9): 695-696, 2018 Sep.
Article
en En
| MEDLINE
| ID: mdl-29939954
ABSTRACT
Prostate cancer is one of the most common cancers affecting men worldwide with a high recurrence rate following therapy. F-fluciclovine, is a US Food and Drug Administration-approved radiopharmaceutical for PET imaging in biochemically recurrent prostate cancer. It targets increased amino acid transporters in the cell membrane of cancer cells. We report a case of incidentally detected hepatocellular carcinoma showing F-fluciclovine uptake in a 71-year-old man with biochemically recurrent prostate cancer.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias de la Próstata
/
Ácidos Carboxílicos
/
Carcinoma Hepatocelular
/
Ciclobutanos
/
Hallazgos Incidentales
/
Neoplasias Hepáticas
Tipo de estudio:
Diagnostic_studies
Límite:
Aged
/
Humans
/
Male
Idioma:
En
Revista:
Clin Nucl Med
Año:
2018
Tipo del documento:
Article